AGTX / Agentix Corp. - SEC फाइलिंग, वार्षिक रिपोर्ट, प्रॉक्सी स्टेटमेंट

एजेंटिक्स कार्पोरेशन
US ˙ OTCPK

मूलभूत आँकड़े
CIK 1603345
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Agentix Corp.
SEC Filings (Chronological Order)
यह पृष्ठ SEC फाइलिंग की एक पूरी, कालानुक्रमिक सूची प्रदान करता है, ओनरशिप फाइलिंग को छोड़कर, जो हम अन्यत्र प्रदान करते हैं।
August 22, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CORP.

August 15, 2025 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit

July 16, 2025 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2025 Commission File No. 000-55383

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2025 Commission File No. 000-55383 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX

July 16, 2025 EX-97.1

Executive Compensation Clawback Policy.

EXHIBIT 97.1 AGENTIX CORP. COMPENSATION RECOUPMENT POLICY 1. Purpose and Scope. The Board of Directors (the “Board”) believes that it is in the best interests of Agentix Corp.(the “Company”) and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Board has therefore adopted

July 1, 2025 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2025 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi

February 18, 2025 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

February 14, 2025 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tra

November 18, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX C

November 14, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr

September 25, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CORP.

August 30, 2024 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 Commission File No. 000-55383

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2024 Commission File No. 000-55383 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX

August 30, 2024 EX-97.1

Executive Compensation Clawback Policy.

EXHIBIT 97.1 AGENTIX CORP. COMPENSATION RECOUPMENT POLICY 1. Purpose and Scope. The Board of Directors (the “Board”) believes that it is in the best interests of Agentix Corp.(the “Company”) and its stockholders to create and maintain a culture that emphasizes integrity and accountability and that reinforces the Company’s pay-for-performance compensation philosophy. The Board has therefore adopted

August 15, 2024 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit

July 1, 2024 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2024 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi

February 14, 2024 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

November 20, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX C

November 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: September 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Tr

August 22, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CORP.

August 14, 2023 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: June 30, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transit

July 14, 2023 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2023 Commission File No. 000-55383

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended March 31, 2023 Commission File No. 000-55383 ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EX

July 14, 2023 EX-21.1

List of Subsidiaries of Registrant

EXHIBIT 21.1 Subsidiaries of the Registrant 1. GSL Healthcare, Inc., a Nevada corporation 2. Applied Biopharma LLC, a Nevada limited liability company 3. Agentix Australia Pty Ltd, a proprietary limited company formed under the laws of Australia

July 14, 2023 EX-10.1

First Amendment to the Consulting Agreement, dated September 9, 2022, by and between Agentix Corp. and Salman Hoda Pharma Consulting, Inc.

EXHIBIT 10.1 AGENTIX Corp. FIRST AMENDMENT to the CONSULTING AGREEMENT THIS FIRST AMENDMENT to the CONSULTING AGREEMENT (this "Amendment") is made and entered into as of September 9, 2022 (the “Effective Date”) by and between AGENTIX Corp. (“AGENTIX”) corporation (the "Company") and SALMAN HODA PHARMA CONSULTING INC, a corporation registered in the Province of Ontario, Canada located at 3858 Barle

June 29, 2023 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: March 31, 2023 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transi

February 14, 2023 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

November 14, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX C

August 11, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CORP.

July 18, 2022 10-KT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KT ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-KT ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ☐ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from September 1, 2021 to

June 30, 2022 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on

June 14, 2022 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2022 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (

June 14, 2022 EX-10.1

Consulting Agreement, dated October 1, 2020, by and between alman Hoda Pharma Consulting Inc., an Ontario, Canada, corporation, and the Company.

EXHIBIT 10.1 AGENTIX Corp. CONSULTING AGREEMENT THIS CONLSULTING AGREEMENT (this ?Agreement?) is made and entered into as of October 1, 2020 (the ?Effective Date?) by and between AGENTIX Biopharma Corp. (?AGENTIX?) corporation (the ?Company?) and SALMAN HODA PHARMA CONSULTING INC, a corporation registered in the Province of Ontario, Canada located at (the ?Consultant?). WHEREAS, the Consultant is

April 13, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

March 11, 2022 RW

Agentix Corp. 32932 Pacific Coast Highway, #14-254 Dana Point, California 92629 March 11, 2022

RW 1 agtxrw.htm RW Agentix Corp. 32932 Pacific Coast Highway, #14-254 Dana Point, California 92629 March 11, 2022 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Agentix Corp. Request to Withdraw Registration Statement on Form S-1 SEC File No. 333-248589 Ladies and Gentlemen, Pursuant to Rule 477 promulgated under the Secu

January 13, 2022 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

December 21, 2021 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 agtx8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 20, 2021 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commis

December 21, 2021 EX-10.1

Amendment No. 1 to Patent and Know-How License Agreement, dated October 21, 2021, by and between Agentix Corp. and Research Triangle Institute, d/b/a RTI International

EXHIBIT 10.1

December 21, 2021 EX-99.1

AGENTIX AND RTI INTERNATIONAL ANNOUNCE WORLDWIDE EXCLUSIVE LICENSE AND SERVICES AGREEMENT

EXHIBIT 99.1 AGENTIX AND RTI INTERNATIONAL ANNOUNCE WORLDWIDE EXCLUSIVE LICENSE AND SERVICES AGREEMENT New York, NY: December 20, 2021 / ACCESSWIRE / AGENTIX Corporation (OTC:AGTX), a clinical-stage biopharmaceutical company focused on the development of innovative therapeutics for the treatment of metabolic diseases, announced today it has entered into an amendment to a Patent and Know-How Licens

October 7, 2021 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2021 Commission File No. 000-55383

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2021 Commission File No. 000-55383 AGENTIX CORP. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Employer incorporation or organiza

July 16, 2021 8-K

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

8-K 1 agtx8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2021 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission

July 14, 2021 EX-2.1

Agreement and Plan of Merger (the “Merger Agreement”), dated July 13, 2021, by and among Agentix Corp., AB Merger LLC, a Nevada limited liability company, and Applied Biopharma LLC, a Nevada limited liability company.

EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER BY AND AMONG APPLIED BIOPHARMA LLC (a Nevada limited liability company) AGENTIX CORP. (a Nevada corporation) and AB MERGER LLC (a Nevada limited liability company) THIS AGREEMENT AND PLAN OF MERGER (the ?Agreement?) is entered into as of the 13th day of July 2021, by and among Applied Biopharma LLC, a Nevada limited liability company (?Applied Biopharma?),

July 14, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 agtx8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 13, 2021 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission

July 9, 2021 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

10-Q 1 agtx10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File

June 4, 2021 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 agtx8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2021 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission

May 27, 2021 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2021 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (I

May 27, 2021 EX-10.1

License Agreement dated May 10, 2021, by and between Applied BioPharma LLC, a Nevada limited liability company, and National Health Research Institutes, a Taiwan, Republic of China, entity. (1)(2)

EXHIBIT 10.1 Certain identified information has been excluded from this License Agreement because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed. License Agreement This License Agreement (this ?Agreement?) is entered into as of this 10th day of May, 2021 (the ?Effective Date?), by and between National Health Research Institutes (?NHRI?), and Applied Bioph

March 29, 2021 10-Q

Quarterly Report - FORM 10-Q

10-Q 1 agtx10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission

January 13, 2021 10-Q

Quarterly Report - FORM 10-Q

10-Q 1 agtx10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission

January 8, 2021 S-8 POS

- S-8 POS

S-8 POS 1 agtxs8pos.htm S-8 POS As filed with the Securities and Exchange Commission on January 8, 2021 Registration No. 333-251879 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 to FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AGENTIX CORP. (Exact name of Registrant as Specified in its Charter) Nevada 46-2876282 (State or Other Jurisdic

January 8, 2021 EX-99.1

Agentix Corp. 2021 Stock Incentive Plan

EXHIBIT 99.1 AGENTIX CORP. 2021 Stock Incentive Plan I. PURPOSE The purpose of this AGENTIX CORP. 2021 Stock Incentive Plan is to provide a means through which Agentix Corp., a Nevada corporation, and its Affiliates may attract highly-qualified persons to serve as Employees, Directors and Consultants of the Company and its Affiliates and to provide a means whereby those individuals, whose present

January 4, 2021 EX-99.1

Agentix Corp. 2021 Stock Incentive Plan

EXHIBIT 99.1 AGENTIX CORP. 2021 STOCK INCENTIVE PLAN I. PURPOSE The purpose of this AGENTIX CORP. 2021 STOCK INCENTIVE PLAN is to provide a means through which Agentix Corp., a Nevada corporation, and its Affiliates may attract highly-qualified persons to serve as Employees, Directors and Consultants of the Company and its Affiliates and to provide a means whereby those individuals, whose present

January 4, 2021 S-8

- FORM S-8

S-8 1 agtxs8.htm FORM S-8 As filed with the Securities and Exchange Commission on January 4, 2021 Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AGENTIX CORP. (Exact name of Registrant as Specified in its Charter) Nevada 46-2876282 (State or Other Jurisdiction (I.R.S. Employer of Incorporation or Orga

January 4, 2021 EX-99.2

Agreement Regarding Legal Services dated January 2, 2021, by and between Agentix Corp., a Nevada corporation and Thomas Puzzo.

EXHIBIT 99.2 AGREEMENT REGARDING LEGAL SERVICES This Agreement Regarding Legal Services (the “Agreement”) is made as of January 2, 2021, by and between Agentix Corp., a Nevada corporation (the “Company”), and Thomas Puzzo (the “Stockholder”). WHEREAS, on March 29, 2020, the Company issued 333,000 shares (the “Shares”) of common stock to the Stockholder in exchange and as compensation for the Stock

December 29, 2020 424B3

AGENTIX CORP. Up to 2,750,721 Shares of Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-248589 PROSPECTUS AGENTIX CORP. Up to 2,750,721 Shares of Common Stock This prospectus supplement amends in its entirety the existing base prospectus that forms a part of the Registration Statement on Form S-1 (File No. 333-248589), which initially became effective on September 23, 2020, and a Post-Effective Amendment No. 2 to the Form S-1 ((Fi

December 11, 2020 POS AM

- POS AM

POS AM 1 agtxposam.htm POS AM As filed with the Securities and Exchange Commission on December 11, 2020 SEC File No. 333-248589 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada 2821 46-2876282 (State or

December 11, 2020 EX-21.1

List of subsidiaries of registrant

EXHIBIT 21.1 LIST OF SUBSIDARIES GSL Healthcare, Inc., a Nevada corporation, a wholly-owned subsidiary of the registrant.

December 11, 2020 CORRESP

▀ ▀ ▀ QUICK LAW GROUP PC 1035 PEARL STREET SUITE 403 BOULDER, CO 80302 Phone: 720.259.3393 Facsimile: 303.845.7315

▀ ▀ ▀ QUICK LAW GROUP PC 1035 PEARL STREET SUITE 403 BOULDER, CO 80302 —————- Phone: 720.

December 9, 2020 10-K

Annual Report - FORM 10-K

10-K 1 agtx10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2020 Commission File No. 000-55383 AGENTIX CORP. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Emplo

November 30, 2020 NT 10-K

- NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: August 31, 2020 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Trans

November 23, 2020 10-K/A

Annual Report - FORM 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Amendment No. 1 to FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2019 Commission File No. 000-55383 AGENTIX CORP. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Employer incorp

November 4, 2020 POS AM

- POS AM

POS AM 1 agtxposam.htm POS AM As filed with the Securities and Exchange Commission on November 4, 2020 SEC File No. 333-248589 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada 2821 46-2876282 (State or

November 4, 2020 EX-21.1

List of subsidiaries of registrant

EXHIBIT 21.1 LIST OF SUBSIDARIES GSL Healthcare, Inc., a Nevada corporation, a wholly-owned subsidiary of the registrant.

September 23, 2020 424B3

AGENTIX CORP. Up to 2,750,721 Shares of Common Stock

Filed Pursuant to Rule 424(b)(3) Registration No. 333-248589 PROSPECTUS AGENTIX CORP. Up to 2,750,721 Shares of Common Stock This prospectus relates to the resale of up to 2,750,721 shares of common stock to be offered by the selling stockholders. Our common stock trades in the over-the-counter market and is quoted on the OTC Pink tier of the OTC Markets Group, Inc. under the symbol “AGTX.” Only a

September 22, 2020 SC 13G/A

AGTX / Agentix Corp. / Puzzo Thomas E - SC 13G/A Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 - Exit Filing)* Agentix Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 00848A103 (CUSIP Number) September 3, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which

September 22, 2020 SC 13D/A

AGTX / Agentix Corp. / Winterhalter Michael - SC 13D/A Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Agentix Corp. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 00848A103 (CUSIP Number) Thomas E. Puzzo, Esq. Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105 Tel: (206) 522-2256 (Name, Address

September 18, 2020 CORRESP

-

September 18, 2020 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences Washington, D.C. 20549 Attention: Mr. Jason L. Drory, Esq. Ms. Christine Westbrook, Esq. RE: Agentix Corp. Registration Statement on Form S-1 Originally Filed September 3, 2020, as amended September 15, 2020 and September 17, 2020 Request for Acceleration File No. 333-248589

September 17, 2020 EX-21.1

List of subsidiaries of registrant

EXHIBIT 21.1 LIST OF SUBSIDARIES GSL Healthcare, Inc., a Nevada corporation, a wholly-owned subsidiary of the registrant.

September 17, 2020 CORRESP

-

▀ ▀ ▀ QUICK LAW GROUP PC 1035 PEARL STREET SUITE 403 BOULDER, CO 80302 Phone: 720.

September 17, 2020 S-1/A

- FORM S-1/A

As filed with the Securities and Exchange Commission on September 17, 2020 SEC File No.

September 15, 2020 S-1/A

- FORM S-1/A

S-1/A 1 agtxs1.htm FORM S-1/A As filed with the Securities and Exchange Commission on September 15, 2020 SEC File No. 333-248589 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada 2821 46-2876282 (State or other jurisdi

September 15, 2020 CORRESP

-

■ ■ ■ QUICK LAW GROUP PC 1035 PEARL STREET SUITE 403 BOULDER, CO 80302 Phone: 720.

September 15, 2020 EX-21.1

List of subsidiaries of registrant

EXHIBIT 21.1 LIST OF SUBSIDARIES GSL Healthcare, Inc., a Nevada corporation, a wholly-owned subsidiary of the registrant.

September 9, 2020 8-K/A

Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets - FORM 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A AMENDMENT NO. 1 TO CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2020 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada 000-55383 46-2876282 (State or other jurisdiction (Commission (I.R.S. Emp

September 9, 2020 EX-99.2

UNAUDITED PRO FORMA FINANCIAL INFORMATION

EXHIBIT 99.2 UNAUDITED PRO FORMA FINANCIAL INFORMATION The Unaudited Pro Forma Financial Information reflects financial information that gives effect to the acquisition of GSL Healthcare, Inc., a Nevada corporation formed on April 15, 2020 (GSL), by Agentix Corp., a Nevada corporation (the “Company”), per a Share Exchange Agreement (the “Share Exchange Agreement”) entered into on May 28, 2020, by

September 9, 2020 EX-99.1

GSL Healthcare, Inc. May 31, 2020 Index to the Financial Statements

EXHIBIT 99.1 GSL Healthcare, Inc. May 31, 2020 Index to the Financial Statements Contents Page(s) Reports of Independent Registered Public Accounting Firms 2 Balance sheet from inception (April 15, 2020) to May 31, 2020 3 Statement of Operations from inception (April 15, 2020) to May 31, 2020 4 Statements of Stockholders’ Deficit Balance from inception (April 15, 2020) to May 31, 2020 5 Statements

September 3, 2020 EX-21.1

List of subsidiaries of registrant

EXHIBIT 21.1 LIST OF SUBSIDARIES GSL Healthcare, Inc., a Nevada corporation, a wholly-owned subsidiary of the registrant.

September 3, 2020 S-1

Registration Statement - FORM S-1

As filed with the Securities and Exchange Commission on September 3, 2020 SEC File No.

July 30, 2020 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2020 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (

July 13, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CORP. (

July 8, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2020 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (I

May 29, 2020 8-K

Changes in Control of Registrant, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2020 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (I

May 29, 2020 EX-2.1

Share Exchange Agreement dated May 28, 2020 by and among Agentix Corp, GSL Healthcare, Inc, and the holders of common stock of GSL Healthcare, Inc. (1)

EXHIBIT 2.1 SHARE EXCHANGE AGREEMENT THIS SHARE EXCHANGE AGREEMENT (the “Agreement”) dated as of May 28, 2020 is entered into by and among Agentix Corp., a Nevada corporation (“Agentix”), and GSL Healthcare, Inc., a Nevada corporation (“GSL Healthcare”), and the shareholders of GSL Healthcare listed on Annex A to this Agreement (each, a “Shareholder” and, collectively, the “Shareholders”). RECITAL

May 26, 2020 SC 13D

AGTX / Agentix Corp. / Stevens Scott B - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Agentix Corp. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 00848A103 (CUSIP Number) Scott Stevens Managing Member Grays Peak Ventures LLC 320 Park Avenue, 18th Floor New York, New York 10022 Tel: (212) 506-7050 (Name, Address and Telephone

May 26, 2020 SC 13D/A

AGTX / Agentix Corp. / Winterhalter Michael - SC 13D/A Activist Investment

SC 13D/A 1 agtxsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Agentix Corp. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 00848A103 (CUSIP Number) Thomas E. Puzzo, Esq. Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105

May 26, 2020 SC 13G

AGTX / Agentix Corp. / Puzzo Thomas E - SC 13G Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Original Filing) Agentix Corp. (Name of Issuer) Common Stock (Title of Class of Securities) 00848A103 (CUSIP Number) March 29, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is f

May 26, 2020 EX-99.1

Joint Filing Agreement

EXHIBIT 99.1 JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a Statement on Schedule 13D (including any and all amendments thereto) with respect to the common stock, $0.001 par value per share, of Agentix Corp., a Nevada corporation, and further agree that this Join

May 13, 2020 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2020 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (IR

April 27, 2020 10-Q

Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

April 14, 2020 NT 10-Q

AGTX / Agentix Corp. NT 10-Q - - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: February 29, 2020 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Tra

January 16, 2020 10-Q

AGTX / Agentix Corp. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 AGENTIX CO

December 5, 2019 10-K

AGTX / Agentix Corp. 10-K - Annual Report - FORM 10-K

10-K 1 agtx10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2019 Commission File No. 000-55383 AGENTIX CORP. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Emplo

December 3, 2019 NT 10-K

AGTX / Agentix Corp. NT 10-K - - NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 00848A103 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: August 31, 2019 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Trans

July 15, 2019 10-Q

FWDR / FAIRWIND ENERGY INC. 10-Q - Quarterly Report - FORM 10-Q

10-Q 1 agtx10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File

July 11, 2019 EX-3.1.1

Certificate of Amendment to Articles of Incorporation

EXHIBIT 3.1.1

July 11, 2019 EX-3.1.2

Certificate of Change

EXHIBIT 3.1.2

July 11, 2019 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 10, 2019 Agentix Corp. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-2876282 (

June 27, 2019 DEF 14C

FWDR / FAIRWIND ENERGY INC. DEF 14C - - DEF 14C

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ¨ Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) x Definitive Information Statement FAIRWIND ENERGY, INC. (Name of Registrant as Specified In Its

June 17, 2019 PRE 14C

FWDR / FAIRWIND ENERGY INC. PRE 14C - - PRE 14C

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: x Preliminary Information Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ¨ Definitive Information Statement FAIRWIND ENERGY, INC. (Name of Registrant as Specified In Its

June 11, 2019 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2019 FairWind Energy Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46-28

March 27, 2019 10-Q

FWDR / FAIRWIND ENERGY INC. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND E

January 22, 2019 10-Q

FWDR / FAIRWIND ENERGY INC. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: November 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND

January 14, 2019 NT 10-Q

FWDR / FAIRWIND ENERGY INC. NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: November 30, 2018 o o o o o Transition Report on Form 10-K Transition Report on Form 20-F Transition Report on Form 11-K T

December 10, 2018 EX-16.1

Letter from MaloneBailey LLP, dated December 10, 2018

EXHIBIT 16.1 December 10, 2018 U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 We have read the statements under Item 4.01 of the Current Report on Form 8-K of FairWind Energy Inc. to be filed with the Securities and Exchange Commission on or about December 10, 2018. We agree with all statements pertaining to us. We have no basis on which to agree or disagree with t

December 10, 2018 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 6, 2018 FairWind Energy Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 46

November 16, 2018 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2018 FairWind Energy Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File Number) 4

November 13, 2018 10-K

FWDR / FAIRWIND ENERGY INC. FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2018 Commission File No. 000-55383 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Employer incorporation or o

July 20, 2018 10-Q

FWDR / FAIRWIND ENERGY INC. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND ENERGY

July 17, 2018 NT 10-Q

FWDR / FAIRWIND ENERGY INC. NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: May 31, 2018 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 11-K o Transiti

April 16, 2018 10-Q

FWDR / FAIRWIND ENERGY INC. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND E

January 16, 2018 10-Q

FWDR / FAIRWIND ENERGY INC. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND E

December 18, 2017 10-K

FWDR / FAIRWIND ENERGY INC. FORM 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2017 Commission File No. 000-55383 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Employer incorporation or o

November 30, 2017 NT 10-K

FWDR / FAIRWIND ENERGY INC. NT 10-K

fwdrnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: August 31, 2017 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on For

July 24, 2017 10-Q

FWDR / FAIRWIND ENERGY INC. FORM 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND ENERGY

July 17, 2017 NT 10-Q

FAIRWIND ENERGY NT 10-Q

fwdrnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: May 31, 2017 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 1

April 13, 2017 10-Q

FAIRWIND ENERGY FORM 10-Q (Quarterly Report)

fwdr10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2017 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-5538

January 23, 2017 10-Q

FAIRWIND ENERGY FORM 10-Q (Quarterly Report)

fwdr10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-5538

January 17, 2017 NT 10-Q

FAIRWIND ENERGY NT 10-Q

fwdrnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 CUSIP NUMBER NOTIFICATION OF LATE FILING 30606B100 (Check One): ? Form 10-K ? Form 20-F ? Form 11-K x Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: November 30, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on F

December 12, 2016 10-K

FAIRWIND ENERGY FORM 10-K (Annual Report)

fwdr10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2016 Commission File No. 000-55383 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Employer incorp

November 30, 2016 NT 10-K

FAIRWIND ENERGY NT 10-K

fwdrnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING SEC FILE NUMBER 000-55383 CUSIP NUMBER 30606B100 (Check One): x Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: August 31, 2016 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on For

July 20, 2016 10-Q

FAIRWIND ENERGY FORM 10-Q (Quarterly Report)

fwdr10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAI

July 18, 2016 NT 10-Q

FAIRWIND ENERGY NT 10-Q

fwdrnt10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): o Form 10-K o Form 20-F o Form 11-K x Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: May 31, 2016 o Transition Report on Form 10-K o Transition Report on Form 20-F o Transition Report on Form 1

April 14, 2016 10-Q

FAIRWIND ENERGY FORM 10-Q (Quarterly Report)

fwdr10q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2016 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-5538

January 14, 2016 10-Q

FWDR / FAIRWIND ENERGY INC. 10-Q - Quarterly Report - FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND E

January 5, 2016 EX-16.1

January 5, 2016

fwdrex161.htm EXHIBIT 16.1 January 5, 2016 United States Securities and Exchange Commission 100 F Street, N.E. Washington DC 20549-7561 Re: FairWind Energy Inc. Commission File Number: 000-55383 Commissioners: We have read Item 4.01 of Form 8-K dated January 5, 2016, of FairWind Energy Inc. and are in agreement with the statements contained therein insofar as they relate to our firm. Very truly yo

January 5, 2016 8-K

Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant

fwdr8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2016 FairWind Energy Inc. (Exact name of registrant as specified in its charter) Nevada (State or other jurisdiction of incorporation) 000-55383 (Commission File

December 16, 2015 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2015 Commission File No. 000-55383 FAIRWIND EN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended August 31, 2015 Commission File No. 000-55383 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 46-2876282 (State or other jurisdiction of (I.R.S. Employer incorporation or o

December 16, 2015 EX-10.1

LOCK-UP AND LEAK OUT AGREEMENT

EXHIBIT 10.1 LOCK-UP AND LEAK OUT AGREEMENT This Lock-Up and Leak-Out Agreement (the "Agreement") is made as of June 22, 2015 (the "Effective Date") by and between FairWind Energy Inc., a Nevada corporation (the "Company"), and the undersigned holder of common stock (the "Stockholder") of the Company. WHEREAS, to ensure the development of an orderly trading market in the Company's common stock, th

December 1, 2015 NT 10-K

FAIRWIND ENERGY NT 10-K

fairwindnt10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): x Form 10-K o Form 20-F o Form 11-K o Form 10-Q o Form 10-D o Form N-SAR o Form N-CSR For Period Ended: August 31, 2015 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on

July 20, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended May 31, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND ENERGY

July 16, 2015 NT 10-Q

FAIRWIND ENERGY NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: May 31, 2015 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Transiti

April 17, 2015 POS AM

FAIRWIND ENERGY POS AM

As filed with the Securities and Exchange Commission on April 17, 2015 Registration No.

April 16, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 28, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND E

April 16, 2015 SC 13D

FWDR / FAIRWIND ENERGY INC. / Han Bao Dong - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 FairWind Energy Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 30606B100 (CUSIP Number) Thomas E. Puzzo, Esq. Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105 Tel: (206) 522-2256 (Name, Address and Telepho

April 14, 2015 NT 10-Q

FAIRWIND ENERGY NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC FILE NUMBER 000-55383 NOTIFICATION OF LATE FILING CUSIP NUMBER 30606B100 (Check One): ¨ Form 10-K ¨ Form 20-F ¨ Form 11-K x Form 10-Q ¨ Form 10-D ¨ Form N-SAR ¨ Form N-CSR For Period Ended: February 28, 2015 ¨ Transition Report on Form 10-K ¨ Transition Report on Form 20-F ¨ Transition Report on Form 11-K ¨ Tra

April 8, 2015 SC 13D

FWDR / FAIRWIND ENERGY INC. / Winterhalter Michael - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 FairWind Energy Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 30606B100 (CUSIP Number) Thomas E. Puzzo, Esq. Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105 Tel: (206) 522-2256 (Name, Address and Telepho

April 7, 2015 SC 13D

FWDR / FAIRWIND ENERGY INC. / Krogius Eric - SC 13D Activist Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 FairWind Energy Inc. (Name of Issuer) Common Stock, $.001 Par Value (Title of Class of Securities) 30606B100 (CUSIP Number) Thomas E. Puzzo, Esq. Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105 Tel: (206) 522-2256 (Name, Address and Telepho

February 27, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2014 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 000-55383 FAIRWIND E

February 24, 2015 8-A12G

AGTX / Agentix Corp. 8-A12G - - 8-A12G

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) or 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 FAIRWIND ENERGY INC. (Exact name of Registrant as specified in its charter) Nevada 46-2876282 (State of Incorporation) (I.R.S. EmployerIdentification No.) 14 Monarch Beach Plaza, Suite 254 Monarc

January 9, 2015 CORRESP

AGTX / Agentix Corp. CORRESP - -

FairWind Energy Inc. 14 Monarch Beach Plaza, Suite 254 Monarch Beach, California 92629 (949) 933-5411 January 9, 2015 VIA EDGAR Pamela Long Assistant Director Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549 Re: FairWind Energy Inc. Registration Statement on Form S-1 (File No. 333-194975) Dear Ms. Long: Pursuant to Rule 461(a) of the Securities Act of 1933, as amended, Fa

January 7, 2015 CORRESP

AGTX / Agentix Corp. CORRESP - -

Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105 E-mail: [email protected] / Telephone: (206) 522-2256 / Facsimile: (206) 260-0111 January 7, 2015 VIA EDGAR Pamela Long Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: FairWind Energy Inc. (the “Company”) Amendment No. 2 to Registration Statement on Form S-1 Filed

January 7, 2015 S-1/A

AGTX / Agentix Corp. S-1/A - - FORM S-1/A

S-1/A 1 fairwinds1a.htm FORM S-1/A As filed with the Securities and Exchange Commission on January 7, 2015 Registration No. 333-194975 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 2821 46-2876282 (State or

January 7, 2015 EX-10.5

SUBSCRIPTION AGREEMENT FAIRWIND ENERGY INC.

EXHIBIT 10.5 SUBSCRIPTION AGREEMENT FAIRWIND ENERGY INC. The undersigned (the “Subscriber”) hereby irrevocably subscribes for that number of shares of common stock (the “Shares”) of FairWind Energy Inc., a Nevada corporation (the “Company”), set forth below, upon and subject to the terms and conditions set forth in the Company’s Prospectus dated , 2015, in the United States Securities and Exchange

December 17, 2014 S-1/A

AGTX / Agentix Corp. S-1/A - - FORM S-1/A

As filed with the Securities and Exchange Commission on December 17, 2014 Registration No.

December 17, 2014 CORRESP

AGTX / Agentix Corp. CORRESP - -

Law Offices of Thomas E. Puzzo, PLLC 3823 44th Ave. NE Seattle, Washington 98105 E-mail: [email protected] / Telephone: (206) 522-2256 / Facsimile: (206) 260-0111 December 17, 2014 VIA EDGAR Pamela Long Assistant Director U.S. Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: FairWind Energy Inc. (the “Company”) Amendment No. 1 to Registration Statement on Form S-1 File

October 31, 2014 EX-10.2

Fairwind Energy Inc. 234 Monarch Bay Plaza, Suite 254 Monarch Beach, California 92629 April 30, 2014

EX-10.2 3 fairwindex102.htm LETTER AGREEMENT WITH MICHAEL WINTERHALTER EXHIBIT 10.2 Fairwind Energy Inc. 234 Monarch Bay Plaza, Suite 254 Monarch Beach, California 92629 April 30, 2014 Michael Winterhalter This letter agreement, dated April 30, 2014 memorializes the terms and conditions of an agreement of compensation by and between Michael Winterhalter (“Winterhalter”) and FairWind Energy Inc., a

October 31, 2014 EX-10.3

Fairwind Energy Inc. 234 Monarch Bay Plaza, Suite 254 Monarch Beach, California 92629 April 30, 2014

EX-10.3 4 fairwindex103.htm LETTER AGREEMENT WITH ERIC KROGIUS EXHIBIT 10.3 Fairwind Energy Inc. 234 Monarch Bay Plaza, Suite 254 Monarch Beach, California 92629 April 30, 2014 Eric Krogius Dear Mr. Krogius: This letter agreement, dated April 30, 2014 memorializes the terms and conditions of an agreement of compensation by and between Eric Krogius (“Krogius”) and FairWind Energy Inc., a Nevada cor

October 31, 2014 EX-10.4

FAIRWIND ENERGY EMPLOYMENT CONTRACT

EXHIBIT 10.4 FAIRWIND ENERGY EMPLOYMENT CONTRACT THIS AGREEMENT, made as of the 15th day of May, 2014. Between: FairWind Energy, Inc., a company incorporated pursuant to the laws of Nevada (hereinafter referred to as "the Employer") - and - Martin Wang, of Mission Viejo, CA (hereinafter referred to as "the Employee") 1. Term of Employment The employment of the Employee shall commence the date here

October 31, 2014 S-1/A

AGTX / Agentix Corp. S-1/A - - FORM S-1/A

S-1/A 1 fairwinds1a.htm FORM S-1/A As filed with the Securities and Exchange Commission on October 31 , 2014 Registration No. 333-194975 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 2821 46-2876282 (State o

April 1, 2014 EX-3.1.1

Articles of Incorporation (1)

EXHIBIT 3.1.1 ROSS MILLER Secretary of State 206 North Carson Street Carson City, Nevada 89701-4299 (775) 684-5708 Website: www.nvsos.gov Filed in the office of /s/ Ross Miller Ross Miller Secretary of State State of Nevada Document Number 20130258615-73 ARTICLES OF INCORPORATION (PURSUANT TO NRS CHAPTER 78) Filing Date and Time 04/18/2013 1:35 PM Entity Number E0194542913-6 1. Name of Corporation

April 1, 2014 EX-3.2.1

Bylaws (1)

EXHIBIT 3.2.1 BYLAWS OF FAIRWIND ENERGY INC. (a Nevada corporation) ARTICLE I Meetings of Stockholders and Other Stockholder Matters SECTION 1. Annual Meeting. An annual meeting of the stockholders of Fairwind Energy Inc., a Nevada corporation (hereinafter, the “Corporation”) shall be held for the election of directors and for the transaction of such other proper business at such time, date and pl

April 1, 2014 S-1

Registration Statement - FORM S-1

S-1 1 fairwinds1.htm FORM S-1 As filed with the Securities and Exchange Commission on April 1, 2014 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 FAIRWIND ENERGY INC. (Exact name of registrant as specified in its charter) Nevada 2821 46-2876282 (State or Other Jurisdiction of (Primary S

April 1, 2014 EX-3.1.2

Articles of Association for Xingcheng SK Composite Co., Ltd. (1)

EXHIBIT 3.1.2

April 1, 2014 EX-10.1

EX-10.1

EXHIBIT 10.1

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista